n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with ovalbumin in 1 studies
| Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
|---|---|---|---|---|---|
| 79 | 1 | 16 | 19,565 | 63 | 5,664 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakiuchi, T; Kasai, M; Kominami, E; Mizuochi, T; Muno, D; Yee, ST | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and ovalbumin
| Article | Year |
|---|---|
Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.
Topics: Animals; Antigen Presentation; Antigen-Presenting Cells; Antigens, Differentiation, B-Lymphocyte; B-Lymphocytes; Cathepsin B; Cathepsin D; Cell Line; Cysteine Proteinase Inhibitors; Dipeptides; Histocompatibility Antigens Class II; Humans; Interleukin-2; Leucine; Major Histocompatibility Complex; Mice; Ovalbumin; Pepstatins; T-Lymphocytes, Helper-Inducer; Tumor Cells, Cultured | 1994 |